Endostim
St. Louis, US · Delaware corporation · 1 known investors
EndoStim develops a neurostimulation medical device system for treating drug-resistant gastroesophageal reflux disease (GERD) by restoring esophageal function while preserving normal anatomy.
Founders & leadership
EG
Eric GoornoChief Executive Officer
GW
Greg WilsonChief Financial Officer
SA
Stephen Attwood, MDSurgical Director
VS
Virender Sharma, MDChief Medical Officer
HA
Hazim AnsariChief Legal Counsel
BJ
Bevil J. HoggExecutive Officer, Director
PG
Paul GoodeExecutive Officer
PS
Peggy S. StohrExecutive Officer
RE
Raul E. PerezDirector
DD
Douglas D. FrenchDirector
VK
Virender K. SharmaDirector
RG
Ralph G. DaceyDirector
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$2.8MraisedDec 2018 · 4 investors · Other Health CareRule 506(b)
▶$2.8MraisedDec 2018 · 4 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Brian FarleyDirector
- Paul V. GoodeExecutive Officer
- Alexander SchmitzDirector
- Virender K. SharmaExecutive Officer
- Douglas D. FrenchDirector
- Offering amount
- $7M
- Amount sold
- $2.8M
- First sale
- Dec 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$12.1MraisedJan 2018 · 20 investors · Other Health CareRule 506(b)
▶$12.1MraisedJan 2018 · 20 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Rohan J. HoareExecutive Officer, Director
- Douglas D. FrenchDirector
- Kimberly PinsonExecutive Officer
- Alexander SchmitzDirector
- Paul GoodeExecutive Officer
- Virender K. SharmaExecutive Officer
- Offering amount
- $25M
- Amount sold
- $12.1M
- First sale
- Dec 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$11.1MraisedMar 2016 · 83 investors · Other Health CareRule 506(b)
▶$11.1MraisedMar 2016 · 83 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Alexander SchmitzDirector
- Paul GoodeExecutive Officer
- Peggy S. StohrExecutive Officer
- Shai PolickerExecutive Officer
- Douglas D. FrenchDirector
- Bevil J. HoggExecutive Officer, Director
- Offering amount
- $20M
- Amount sold
- $11.1M
- First sale
- Mar 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.5MraisedMay 2015 · 1 investors · Other Health CareRule 506(b)
▶$2.5MraisedMay 2015 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Bevil J. HoggExecutive Officer, Director
- Paul GoodeExecutive Officer
- Peggy S. StohrExecutive Officer
- Raul E. PerezDirector
- Douglas D. FrenchDirector
- Virender K. SharmaDirector
- Ralph G. DaceyDirector
- Jeffrey M. McDonnellDirector
- Shai PolickerExecutive Officer
- Fred C. GoadDirector
- Offering amount
- $5M
- Amount sold
- $2.5M
- Minimum investment
- $2.5M
- First sale
- May 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
- EndoStim raises $25m Series D for neurostim GERD device - MassDevicemassdevice.com · 2016